AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Press Release)
Goodkind Labaton Rudoff & Sucharow LLP filed an antitrust class action in the US District Court for the Southern District of New York on behalf of Union Welfare Funds, challenging alleged deceptive and monopolistic acts of Purdue Pharma and Purdue Pharma LP, The Purdue Frederick Co, The PF Laboratories Inc, The Purdue Pharma Co, Abbott Laboratories, and Euroceltique SA in sales of OxyContin (controlled-release oxycodone hydrochloride prescription tablets). The complaint alleges that Purdue Pharma obtained exclusive selling rights of oxycodone hydrochlorine by virtue of inequitable conduct, including misrepresentations …